Limited evidence derived from the oligometastatic context constrains optimal patient selection and timing strategies in oligoprogressive RCC. Following the establishment of consensus over definitions and research gaps, future research integrating molecular biomarkers, novel imaging tracers, and multicentre collaborative studies will be essential to develop evidence-based surgical management protocols for this increasingly common clinical scenario.
Building similarity graph...
Analyzing shared references across papers
Loading...
C. Re
Will Ince
Leo Bickley
BJU International
University of Cambridge
Western General Hospital
Vita-Salute San Raffaele University
Building similarity graph...
Analyzing shared references across papers
Loading...
Re et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69df2ae6e4eeef8a2a6afd9c — DOI: https://doi.org/10.1111/bju.70281